Search Results
Cardiovascular Outcomes Trials With Anti-Diabetes Medications
CV Effects of Diabetes Medications: Lessons learned from Cardiovascular Outcomes Trials
DRF 19: Cardiovascular Outcomes for Diabetes Drugs: Lessons Learned and Path Forward
Cardioprotective Effects of Newer Antidiabetes Medications, February 21, 2020
Understanding Cardiovascular Outcomes Trials
Semaglutide and Cardiovascular Outcomes in Obesity | NEJM
Diabetes Remission & Lifestyle Update What Every Clinician Needs to Know- Part 2
Cardiovascular Outcomes in Patients with Diabetes
Designing Better Cardiovascular Outcomes Trials in Diabetes
Examining Cardiovascular Outcomes Trials
SGLT2 inhibitors and cardiovascular outcomes in type 2 diabetes: VERTIS CV trial
Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors